Under construction – not a live service
Sign in
Not yet taking people in BelgiumNo phase

HABIT-ILE Therapy Trial for Adults Recovering From Stroke

Tests HABIT-ILE intensive therapy in adults with recent stroke recovery.

Plain-language title generated from the registry record
Registry title: Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) - Adult

Key facts

Where
Brussels, BelgiumSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 95 years old?

Source: NCT06931795, who can take part

Where in Belgium

  • Institute of Neurosciences, UCLouvainBrussels, BelgiumNo longer taking part
  • Spontaneous contact via doctors or other partnersBrussels, BelgiumNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Université Catholique de Louvain
Trial code
NCT06931795
Record updated
17 April 2025
Original description
Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of patients with sub-acute post-strokeRead full original descriptionShow less

Implementation of a HABIT-ILE Intervention at the William Lennox Neurological Centre for Sub-acute Adult Post-stroke Patients (<6 Mois): a Randomised Controlled Trial

Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of patients with sub-acute post-stroke

Inclusion: Phase aiguë ou subaiguë.

Exclusion: Epilepsie instable; Absence à déterminer sa volonté à participer; Traitement toxine pendant le stage.

ClinicalTrials.gov NCT06931795